Does ELTROMBOPAG Cause Mobility decreased? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Mobility decreased have been filed in association with ELTROMBOPAG. This represents 0.2% of all adverse event reports for ELTROMBOPAG.
10
Reports of Mobility decreased with ELTROMBOPAG
0.2%
of all ELTROMBOPAG reports
0
Deaths
8
Hospitalizations
How Dangerous Is Mobility decreased From ELTROMBOPAG?
Of the 10 reports, 8 (80.0%) required hospitalization, and 4 (40.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG Cause?
Platelet count decreased (968)
Death (629)
Drug ineffective (554)
Product use in unapproved indication (303)
Thrombocytopenia (262)
Off label use (255)
Headache (229)
Pyrexia (229)
Haemoglobin decreased (213)
Pneumonia (204)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ELTROMBOPAG Alternatives Have Lower Mobility decreased Risk?
ELTROMBOPAG vs ELTROMBOPAG OLAMINE
ELTROMBOPAG vs ELUXADOLINE
ELTROMBOPAG vs ELVITEGRAVIR
ELTROMBOPAG vs EMAPALUMAB
ELTROMBOPAG vs EMAPALUMAB-LZSG